Humacyte, Inc.
HUMA
$2.53
$0.135.42%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/24/2025
-
MarketBeat
5/22/2025
-
Ticker Report
5/21/2025
-
Simply Wall St
5/20/2025
-
ETF Channel
5/20/2025
-
MarketBeat
5/20/2025
-
MarketBeat
5/19/2025
-
GuruFocus
5/19/2025
-
GuruFocus
5/19/2025
-
Globe Newswire
5/17/2025
-
TipRanks Financial Blog
5/17/2025
-
Ticker Report
5/15/2025
-
MarketBeat
5/14/2025
-
GuruFocus
5/14/2025
-
GuruFocus
5/14/2025
-
The Fly
5/14/2025
-
GuruFocus
5/14/2025
-
GuruFocus
5/14/2025
-
The Fly
5/14/2025
-
Bizjournals.com - Health Care News
5/14/2025
-
Ticker Report
5/14/2025
-
GuruFocus
5/14/2025
-
TipRanks Financial Blog
5/14/2025
-
GuruFocus
5/13/2025
-
GuruFocus
5/13/2025
-
Seeking Alpha: Transcripts
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 13, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
919-313-9633
Address
2525 East North Carolina Highway 54
Durham, NC 27713
Durham, NC 27713
Country
Year Founded
Business Description
Sector
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and...
more